[1]欧阳凌霞, 周攀, 陆海娜. 慢性肾脏病流行病学研究现状[J]. 国际移植与血液净化杂志, 2012, 10(3): 1-3. [2]陈崴, 王辉, 董秀清, 等. 广州市城区普通人群中慢性肾脏病的流行病学研究[J]. 中华肾脏病杂志, 2007, 23(3): 147-151. [3]王德光, 郝丽, 戴宏, 等. 安徽省成人慢性肾脏病流行病学调查[J]. 中华肾脏病杂志, 2012, 28(2): 101-105. [4]阳晓. 慢性肾脏病进展的危险因素及延缓策略[J]. 中国实用内科杂志, 2008, 28(1): 79-80. [5]HENSLEY M K. Historical Perspective of Nutrition in Kidney Disease[M]. Totowa, NJ: Humana Press, 2008. [6]方仕, 麦海妍, 卢味, 等. 住院患者营养风险筛查及营养支持状况[J]. 中国公共卫生, 2010, 26(5): 574-575. [7]HSU C Y, MCCULLOCH C E, IRIBARREN C, et al. Body mass index and risk for end-stage renal disease[J]. Ann Intern Med, 2006, 144(1): 21. [8]郑法雷. 慢性肾脏病患者的营养治疗:明确目标,改进指导[J]. 肾脏病与透析肾移植杂志, 2017, 26(4): 345-346. [9]张娜, 王小琴. 慢性肾脏病非透析患者营养治疗的研究进展[J]. 临床肾脏病杂志, 2016(12): 755-759. [10] 石汉平, 李增宁, 王昆华, 等. 营养管理新模式-HCH[J]. 肿瘤代谢与营养电子杂志, 2015, 2(3): 23-26. [11] 景小凡, 柳园, 饶志勇, 等. 构建“H2H"营养管理模式: 以肿瘤患者为例[J]. 现代预防医学, 2016, 43(2): 243-245. [12] LIM V S, FLANIGAN M J. Protein intake in patients with renal failure: comments on the current NKF-DOQI guidelines for nutrition in chronic renal failure[J]. Semin Dial, 2001, 14(3): 150-152. [13] CHEN X R, WEI G, JALILI T, et al. The associations of plant protein intake with all-cause mortality in CKD[J]. American Journal of Kidney Diseases, 2016, 67(3): 423-430. [14] 林善锬. 重视慢性肾脏疾病患者营养问题的研究[J]. 上海医学, 2002, 25(11): 669-670. [15] KOPPLE J D. National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure[J]. Am J Kidney Dis, 2001, 37(1 Suppl 2): S66-S70. [16] 陈艳鸿, 曲黔, 陈丽珠, 等. 饮食指导模式对提高慢性肾脏病患者低蛋白饮食治疗依从性研究[J]. 现代诊断与治疗, 2013, 24(4): 723-726. [17] 中华医学会. 临床诊疗指南-肾脏病学分册[M]. 北京: 人民卫生出版社, 2011. [18] FOUQUE D, APARICIO M. Eleven reasons to control the protein intake of patients with chronic kidney disease[J]. Nat Clin Pract Nephrol, 2007, 3(7): 383-392. [19] CORESH J, ASTOR B C, GREENE T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey[J]. Am J Kidney Dis, 2003, 41(1): 1-12. [20] COLLINS A J, FOLEY R N, CHAVERS B, et al. 'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States[J]. Am J Kidney Dis, 2012, 59(1 Suppl 1): A7, e1-A7,420. [21] LI P K, KWAN B C, LEUNG C B, et al. Prevalence of silent kidney disease in Hong Kong: the screening for Hong Kong Asymptomatic Renal Population and Evaluation(SHARE)program[J]. Kidney Int Suppl, 2005(94): S36-S40. [22] HALL J E, CROOK E D, JONES D W, et al. Mechanisms of obesity-associated cardiovascular and renal disease[J]. Am J Med Sci, 2002, 324(3): 127-137. [23] SHEN W W, CHEN H M, CHEN H, et al. Obesity-related glomerulopathy: body mass index and proteinuria[J]. CJASN, 2010, 5(8): 1401-1409. [24] MORALES E, VALERO M A, LEON M, et al. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies[J]. Am J Kidney Dis, 2003, 41(2): 319-327. [25] 夏清山. 肾脏病的营养研究[J]. 鄂州大学学报, 2015, 22(7): 109-110. [26] 唐雯, 鲁新红, 汪涛. 慢性肾脏病饮食营养管理[J]. 中国实用内科杂志, 2010, 30(6): 516-517. [27] 鲁新红, 陆潜, 汪涛, 等. 慢性肾衰竭病人的饮食现状调查[J]. 护理研究, 2008, 22(28): 2560-2562. [28] 贾文娟. 慢性肾脏病3-4期住院患者的营养状况调查及相关因素分析[D]. 杭州: 浙江大学, 2011. [29] QURESHI A R, ALVESTRAND A, DIVINO-FILHO J C, et al. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients[J]. J Am Soc Nephrol, 2002, 13(Suppl 1): S28-S36. [30] DE MUTSERT R, GROOTENDORST D C, AXELSSON J, et al. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients[J]. Nephrol Dial Transplant, 2008, 23(9): 2957-2964. [31] FLANIGAN M J, ROCCO M V, FRANKENFIELD D, et al. 1997 peritoneal dialysis-core indicators study: dialysis adequacy and nutritional indicators report[J]. Am J Kidney Dis, 1999, 33(6): e3. [32] 鲁新红, 路潜. 临床营养护理[J]. 护士进修杂志, 2007, 22(21): 1925-1926. [33] NUGENT R A, FATHIMA S F, FEIGL A B, et al. The burden of chronic kidney disease on developing nations: a 21st century challenge in global health[J]. Nephron Clin Pract, 2011, 118(3): c269-c277. [34] WOO K T, CHOONG H L, WONG K S, et al. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases[J]. Kidney Int, 2012, 81(10): 1044-1045. [35] ZHANG L X, WANG H Y. Chronic kidney disease epidemic: cost and health care implications in China[J]. Semin Nephrol, 2009, 29(5): 483-486. [36] ZHANG L X, ZUO L, XU G B, et al. Community-based screening for chronic kidney disease among populations older than 40 years in Beijing[J]. Nephrol Dial Transplant, 2007, 22(4): 1093-1099. [37] CHEN N, WANG W M, HUANG Y P, et al. Community-based study on CKD subjects and the associated risk factors[J]. Nephrol Dial Transplant, 2009, 24(7): 2117-2123. [38] XUE C, YE X D, LI W, et al. Prevalence of chronic kidney disease in Jing adults in China: a village-based study[J]. Clin Nephrol, 2013, 79(1): 50-56. [39] GU D F, SHI Y L, CHEN Y M, et al. Prevalence of chronic kidney disease and prediabetes and associated risk factors: a community-based screening in Zhuhai, Southern China[J]. Chin Med J, 2013, 126(7): 1213-1219. [40] LIN B, SHAO L N, LUO Q, et al. Prevalence of chronic kidney disease and its association with metabolic diseases: a cross-sectional survey in Zhejiang province, Eastern China[J]. BMC Nephrol, 2014, 15: 36. [41] ZHANG L X, WANG F, WANG L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet, 2012, 379(9818): 815-822.
